Home Newsfeeds Maxim Group Downgrades Aridis Pharmaceuticals to Hold

Maxim Group Downgrades Aridis Pharmaceuticals to Hold

Maxim Group analyst Jason McCarthy downgrades Aridis Pharmaceuticals (NASDAQ:ARDS) from Buy to Hold.

byBenzinga Newsdesk

August 16, 2022

1 minute read

Maxim Group analyst Jason McCarthy downgrades Aridis Pharmaceuticals (NASDAQ:ARDS) from Buy to Hold.

Barclays Maintains Equal-Weight on UiPath, Lowers Price Target to $13

By Benzinga Newsdesk

January 10, 8:14 AM

Barclays analyst Raimo Lenschow maintains UiPath (NYSE:PATH) with a Equal-Weight and lowers the price target from $15 to $13.

PATH

Instagram Meets Pinterest: TikTok Ban Could Be Coming, Parent Company ByteDance Might Have An Answer With Lemon8

By Chris Katje

March 29, 12:40 PM

The battle for dominance in social media and short-form video content in the U.S. has seen TikTok become one of the biggest apps in the country. TikTok has seen others try to emulate its features and could benefit from a potential ban. But TikTok’s parent company might have a backup plan in the works.

‘Sales Of Japanese Carmakers Toyota, Nissan And Honda sink In China As They Fall Behind In EV Race’ – SCMP

By Happy Mohamed

July 18, 9:43 AM

https://www.scmp.com/business/china-business/article/3228145/sales-japanese-carmakers-toyota-nissan-and-honda-sink-china-they-fall-behind-ev-race?module=live&pgtype=homepage Japan’s top six carmakers –

EWJ